AR051314A1 - METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILIPSY. PHARMACEUTICAL COMPOSITION AND KIT. - Google Patents
METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILIPSY. PHARMACEUTICAL COMPOSITION AND KIT.Info
- Publication number
- AR051314A1 AR051314A1 ARP050104150A AR051314A1 AR 051314 A1 AR051314 A1 AR 051314A1 AR P050104150 A ARP050104150 A AR P050104150A AR 051314 A1 AR051314 A1 AR 051314A1
- Authority
- AR
- Argentina
- Prior art keywords
- epileptogenesis
- group
- methods
- phenyl
- alkyl
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Métodos para prevenir, tratar, revertir, inhibir o detener la epilepsia y la epileptogénesis en un sujeto, que comprenden administrar al sujeto que lo necesita una cantidad terapéuticamente efectiva e un compuesto seleccionado el grupo formado por la formula (1) y la formula (2), o una de sus sales o ésteres aceptables desde el punto de vista farmacéutico, en las cuales fenilo está sustituido en X con uno a cinco átomos de halogeno seleccionados del grupo formado por F, Cl, Br, e I; y R1, R2, R3, R4, R5 y R6 se seleccionan en forma independiente del grupo formado por H y alquilo C1-4; donde el alquilo C1-4 está sustituido en forma opcional con fenilo (donde fenilo está sustituido en forma opcional con sustituyentes seleccionados en forma independiente del grupo formado por halogeno, alquilo C1-4, alcoxi C1-4, amino, nitro y ciano).Methods for preventing, treating, reversing, inhibiting or stopping epilepsy and epileptogenesis in a subject, comprising administering to the subject in need a therapeutically effective amount and a compound selected from the group formed by the formula (1) and the formula (2 ), or one of its pharmaceutically acceptable salts or esters, in which phenyl is substituted on X with one to five halogen atoms selected from the group consisting of F, Cl, Br, and I; and R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of H and C1-4 alkyl; wherein C1-4 alkyl is optionally substituted with phenyl (where phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-4 alkyl, C1-4 alkoxy, amino, nitro and cyano).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69862505P | 2005-07-12 | 2005-07-12 | |
| US70724205P | 2005-08-11 | 2005-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051314A1 true AR051314A1 (en) | 2007-01-03 |
Family
ID=37600951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104150 AR051314A1 (en) | 2005-07-12 | 2005-09-30 | METHODS OF TREATMENT OF EPILEPTOGENESIS AND EPILIPSY. PHARMACEUTICAL COMPOSITION AND KIT. |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR051314A1 (en) |
| PE (1) | PE20061039A1 (en) |
| TW (1) | TW200701978A (en) |
| UY (1) | UY29158A1 (en) |
-
2005
- 2005-09-19 TW TW094132376A patent/TW200701978A/en unknown
- 2005-09-30 AR ARP050104150 patent/AR051314A1/en not_active Application Discontinuation
- 2005-09-30 PE PE2005001163A patent/PE20061039A1/en not_active Application Discontinuation
- 2005-10-07 UY UY29158A patent/UY29158A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200701978A (en) | 2007-01-16 |
| PE20061039A1 (en) | 2006-11-08 |
| UY29158A1 (en) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054550A1 (en) | METHODS TO TREAT EPILEPTOGENESIS | |
| PE20191541A1 (en) | COMPOSITIONS AND METHODS TO INHIBIT THE ACTION OF ARGINASE | |
| BRPI0515374A (en) | Methods of treatment of epileptogenesis and epilepsy | |
| AR060991A1 (en) | CARBOXILIC ACIDS REPLACED WITH 4,5-DIFENYL PYRIMIDINYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM USED FOR THE TREATMENT OF DIABETES | |
| PE20110062A1 (en) | N- (3- (3,5-DIMETOXIFENETTIL) -1H-PIRAZOL-5-IL) -4- (3,4-DIMETILPIPERAZIN-1-IL) BENZAMIDE AND SALTS OF THE SAME | |
| ATE536349T1 (en) | 1H-BENZIMIDAZOLE-4-CARBONIC ACID AMIDES SUBSTITUTED IN THE 2 POSITION BY PHENYL ARE EFFECTIVE PARP INHIBITORS | |
| DK1487444T3 (en) | Use of pyridylamides as angiogenesis inhibitors | |
| ECSP088179A (en) | CARBAMATE COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| AR042941A1 (en) | DERIVATIVES OF TIAZOL, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF INHIBITING MEDICINES OF VASCULAR ADHESION PROTEIN-1 (VAP-1) | |
| PE20090694A1 (en) | SIRTUIN MODULATING COMPOUNDS | |
| AR064010A1 (en) | AKT ACTIVITY INHIBITORS | |
| PE20060680A1 (en) | SUBSTITUTE MORPHOLIN COMPOUNDS AS INHIBITORS OF NOREPINEPHRINE RECAPTATION | |
| AR053554A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
| AR053774A1 (en) | DERIVATIVES OF SULFONILBENCIMIDAZOL. PHARMACEUTICAL COMPOSITIONS. | |
| PA8555401A1 (en) | QUINOLINE DERIVATIVES | |
| NZ597376A (en) | Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases | |
| AR054524A1 (en) | METHODS AND DOSAGE FORMS TO REDUCE THE SIDE EFFECTS OF CARBAMATE COMPOUNDS | |
| AR052885A1 (en) | QT INTERVAL CONTROL METHODS | |
| PE20081160A1 (en) | ARILSULFONIL-PYRROLIDINES AS 5-HT6 INHIBITORS | |
| AR057005A1 (en) | DERIVATIVES OF 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT | |
| ECSP077395A (en) | CARBAMATE COMPOUND FOR USE IN THE TREATMENT OF NEURODEGENERATIVE PADCIMIENTS | |
| CO6180505A2 (en) | METHODS FOR THE TREATMENT OF COCLEAR AND VESTIBULAR DISORDERS | |
| AR054220A1 (en) | 5-PHENYL PYRIMIDINES I REPLACED, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| ATE432262T1 (en) | PYRAZOLEPHENYL DERIVATIVES AS PPAR ACTIVATORS | |
| AR032876A1 (en) | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |